BioAdvance Commits $2.9M to 15 Life Sciences Companies

PHILADELPHIA–(BUSINESS WIRE)–BioAdvance announced that during the past 12 months it added nine new companies and technologies to its portfolio and made follow-on investments in six of its existing companies. Overall, these investments represent a $2.9M commitment to the success and growth of life science companies and to this region.

To Learn More